Patient Safety

In a new study published in the Journal of Clinical Oncology, researchers found that smokers treated for breast cancer have a higher risk than non-smokers when it comes to developing lung cancer or heart attack as a result of radiotherapy.

Utilizing two dose-reduction strategies during lung biopsies has a long-term effect on lowering patient dose, according to a University of California San Fransisco study. The last decade in radiology has seen a shift away from high-power imaging to strategies attempting to curb patient dose such as the Image Gently campaign. CT biopsies in particular can result in high doses by virtue of repeated imaging during their three-step process, presenting a clear opportunity for dose-reduction.

Maintaining a rigorous log of patient gadolinium dosage should be a priority for radiology departments and imaging centers, according to Hans-Klaus Goischke, Dr. med.

It is a question that continues to inspire contentious debate within radiology and the greater medical profession: How harmful is imaging-related radiation exposure?

The reasons for gadolinium accumulation—and the potential negative consequences for patients—are still largely unknown, due in part to limited existing clinical data regarding the mechanisms of gadolinium toxicity, according to a research review recently published in the journal Biometals.

When doctors at the University of Colorado Hospital noticed an alarming increase in instances of retained surgical items (RSIs) at their high-volume surgical center, they knew they had to investigate and rectify the problem immediately.

There is no proof that radiation from medical imaging causes cancer, and the persistence of any perceived dangers is based on unproven and outdated information, according to the authors of a recently released study published online in the American Journal of Clinical Oncology.

When Carol Krucoff collapsed after drinking too much water during a marathon, she had no knowledge of the tiny tumor growing inside her brain. She would get to know it intimately over the next 10 years, employing a “watchful waiting” strategey to closely monitor the tumor while withholding treatment unless symptoms appear.